Jonathan Lewis
2012
In 2012, Jonathan Lewis earned a total compensation of $1.6M as Chief Executive Officer at ZIOPHARM Oncology, a 48% increase compared to previous year.
Compensation breakdown
| Bonus | $97,020 |
|---|---|
| Option Awards | $875,940 |
| Salary | $485,100 |
| Other | $122,789 |
| Total | $1,580,849 |
Lewis received $875.9K in option awards, accounting for 55% of the total pay in 2012.
Lewis also received $97K in bonus, $485.1K in salary and $122.8K in other compensation.
Rankings
In 2012, Jonathan Lewis' compensation ranked 4,374th out of 11,487 executives tracked by ExecPay. In other words, Lewis earned more than 61.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,374 out of 11,487 | 62nd |
Division Manufacturing | 1,515 out of 4,253 | 64th |
Major group Chemicals And Allied Products | 346 out of 1,203 | 71st |
Industry group Drugs | 213 out of 925 | 77th |
Industry Pharmaceutical Preparations | 164 out of 700 | 77th |
Source: SEC filing on April 30, 2014.
Lewis' colleagues
We found four more compensation records of executives who worked with Jonathan Lewis at ZIOPHARM Oncology in 2012.